GELS Stock Analysis: Buy, Sell, or Hold?
GELS - Gelteq Limited Ordinary Shares
$0.60
-0.09 (-13.03%)
▼
5d:
-47.35%
30d:
+42.23%
90d:
-16.46%
WAIT
LOW Confidence
Analysis Updated: Jun 25, 2026 12:00 AM ET
Get Alerted When GELS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GELS is down 47.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GELS is down 47.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GELS is currently trading at $0.60, which is considered fair relative to its 30-day fair value range of $0.35 to $0.97.
Technical Outlook: Technically, GELS is in a strong downtrend. The price is approaching resistance at $0.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 13.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GELS is in a strong downtrend. The price is approaching resistance at $0.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 13.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.35 -
$0.97
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
60.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-13.0%)
- WARNING: Recommendation downgraded due to -47.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.35 -
$0.97
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.41
Resistance Level
$0.55
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Revenue Growth (YoY)
59.4%
Share & Embed Analysis
Last updated: June 25, 2026 11:08 PM ET
Data refreshes hourly during market hours. Next update: 12:08 AM
Data refreshes hourly during market hours. Next update: 12:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GELS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 61 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 59 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 56 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 57 HOLD |
